A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).
Issuance of EUR 5 million convertible bond with exclusion of subscription rights – Biotech Investments
BRAIN Biotech AG / Key word(s): Bond BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights 29-Feb-2024 / 20:06